-
effectivehealthcare.ahrq.gov/news/grand-rounds-mhs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
April 28, 2010 - evidence that the service improves important health
outcomes and concludes that benefits outweigh harms … We found no evidence of direct harms, aside from
opportunity costs associated with the interventions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cesarean-birth-2010_executive.pdf
January 01, 2010 - We also assessed
the harms of the strategies used, defined by the Evidence-
based Practice Center Program … AHRQ series paper 4:
assessing harms when comparing medical interventions:
AHRQ and the effective
-
effectivehealthcare.ahrq.gov/sites/default/files/module_ii1.ppt
June 01, 2011 - For example, patients & consumers may be most interested in treatment options, benefits and harms, and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d3.xlsx
January 01, 2025 - Metastases Metastases comment Toxicity Toxicity comment Quality of Life/ Patient reported outcomes Harms … and AEs Harms and AEs_comment Data Type Assessment type Assessment time, wk Population Subgroup IG N … NR NR NR NR NR NR NR NR NR NR 847 NR NR NR NR NR
Brand, 2019; Tree, 2022; van As, 2024 KQ2 IG1 IG2 Harms … NR NR NR NR NR NR NR NR NR NR 847 NR NR NR NR NR
Brand, 2019; Tree, 2022; van As, 2024 KQ2 IG1 IG2 Harms … NR NR NR NR NR NR NR NR NR NR 847 NR NR NR NR NR
Brand, 2019; Tree, 2022; van As, 2024 KQ2 IG1 IG2 Harms
-
effectivehealthcare.ahrq.gov/products/postpartum-care-one-year/research
-
effectivehealthcare.ahrq.gov/products/infantile-hemangioma/clinician
-
effectivehealthcare.ahrq.gov/products/social-isolation/protocol
-
effectivehealthcare.ahrq.gov/products/hemorrhage-postpartum/research
-
effectivehealthcare.ahrq.gov/products/recombinant-factor-viia/clinician
-
effectivehealthcare.ahrq.gov/products/hemorrhage-postpartum/clinician
-
effectivehealthcare.ahrq.gov/products/ptsd-adults-trauma-interventions/research
-
effectivehealthcare.ahrq.gov/products/colorectal-cancer-hepatic-therapy/abstract
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain-therapies-future_research.pdf
January 01, 2015 - comparative effectiveness of
various surgical and nonsurgical therapies for noncyclic CPP, as well as harms … nonsurgical interventions on pain status, functional status, satisfaction with care, quality
of life, and harms … identified the
following future research needs related to iatrogenic causes of CPP:
• Benefits and harms … technology); more evidence needed about values and preferences influencing balance of
benefits and harms … Potential risk from inaction: Unintended harms from lack of prioritization of proposed research; opportunity
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
October 30, 2019 - We have added some
additional detail about the
complexity of balancing
potential harms and benefits … how the c-statistic was
interpreted but not interpretation of magnitude of
effects for efficacy/harms … correctly that 'Dabigatran (150mg
dose) is superior to warfarin in reducing stroke with
no difference in harms … reduced the risk of hemorrhagic stroke compared
to warfarin with no difference in other outcomes or
harms … hemorrhagic stroke and major bleeding compared
to warfarin with no difference in other outcomes or
harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_surveillance.pdf
January 01, 2013 - KQ 6: What are the harms associated with screening for open angle glaucoma? … We did not identify any study
addressing the harms associated with
screening for OAG. … KQ 6: What are the harms associated with screening for openangle glaucoma? … We did not identify any study addressing the
harms associated with screening for OAG.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_disposition-comments.pdf
February 01, 2012 - Comment –
Margaret Piper
Discussion/
Conclusion
P37: “we do not expect any clinically significant harms … I suggest that the downstream harms described
are clinically significant; but relative to other tests … that have the
same harms, no more problematic. … We have added a sentence to clarify that the
downstream harms from false positives should
be considered
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - We found no studies describing the safety (or harms) of
echocardiography or biomarker testing. … • We found no studies addressing diagnostic thinking
efficacy, therapeutic efficacy, or harms (insufficient … Twenty-one studies reported harms or adverse
events.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_executive.pdf
August 01, 2014 - development
Maladaptive behaviors
Distress
Adaptive skills development
Social skills/interaction
Harms … Adaptive independence
Academic engagement/
Attainment
Psychological well-being
Psychosocial adaptation
Harms … Similarly, no studies reported
harms of intervention in terms of child, family, or system
impact.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-interventions-maltreatment-child_executive.pdf
April 01, 2013 - Exposed to Maltreatment
We included a KQ examining adverse events because
there is the potential for harms … Such
harms may take the form of retraumatization associated
with gradual exposure or caregiver distress